Mark Tessier-Levine

In this discussion, Matt Kinzela, CEO of Inflection, outlines the integration of quantum technologies with classical systems. George Church, a leading figure in genomics at Lila Sciences, delves into how AI can drive experimentation in synthetic biology. Anirud Devgon from Cadence shares insights on AI's transformative role in chip and system design. Mark Tessier-Levine of Zyra Therapeutics explores AI's potential to revolutionize drug discovery timelines and molecular design, suggesting that AI could change the very nature of biological engineering.